Corvus Pharmaceuticals

Corvus begins phase 1 Covid-19 clinical trial with novel immunotherapy

Submitted by admin on Wed, 07/08/2020 - 10:34

snippet

Clinical-stage biopharmaceutical firm Corvus Pharmaceuticals has commenced the phase 1 clinical study of novel Immunotherapy for patients with Covid-19 disease.

Source

Pharmaceutical Business Review

Headline

Corvus begins phase 1 Covid-19 clinical trial with novel immunotherapy

News Tags

Corvus Pharmaceuticals

clinical trials

immunotherapy

COVID-19

CPI-006

Biotech IPOs continue as Corvus prices public listing

Submitted by admin on Thu, 03/24/2016 - 14:04

Source

BioPharma Dive

Headline

Biotech IPOs continue as Corvus prices public listing

News Tags

IPOs

biotech

Corvus Pharmaceuticals

Week Ahead: One Pre-Sold Biotech IPO During A Short Holiday Week

Submitted by admin on Sun, 03/20/2016 - 13:25

Source

Seeking Alpha

Headline

Week Ahead: One Pre-Sold Biotech IPO During A Short Holiday Week

News Tags

Corvus Pharmaceuticals

biotech

IPOs

Biotechs launch an IPO blitz as Nasdaq stumbles out of the gate

Submitted by admin on Tue, 01/05/2016 - 09:44

Source

Fierce Biotech

Headline

Biotechs launch an IPO blitz as Nasdaq stumbles out of the gate

News Tags

Audentes Therapeutics

Bavarian Nordic

Corvus Pharmaceuticals

Reata Pharmaceuticals

Ex-Pharmacyclics team raises $33.5M for checkpoint drug

Submitted by admin on Fri, 07/03/2015 - 19:58

Source

Fierce Biotech

Headline

Ex-Pharmacyclics team raises $33.5M for checkpoint drug

News Tags

Pharmacyclics

Corvus Pharmaceuticals

Subscribe to Corvus Pharmaceuticals